KR20240019063A - 펜알킬아민 및 이의 제조 및 사용 방법 - Google Patents
펜알킬아민 및 이의 제조 및 사용 방법 Download PDFInfo
- Publication number
- KR20240019063A KR20240019063A KR1020237034789A KR20237034789A KR20240019063A KR 20240019063 A KR20240019063 A KR 20240019063A KR 1020237034789 A KR1020237034789 A KR 1020237034789A KR 20237034789 A KR20237034789 A KR 20237034789A KR 20240019063 A KR20240019063 A KR 20240019063A
- Authority
- KR
- South Korea
- Prior art keywords
- mmol
- alkyl
- hydrogen
- dimethoxy
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/32—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163160292P | 2021-03-12 | 2021-03-12 | |
| US63/160,292 | 2021-03-12 | ||
| PCT/US2022/020196 WO2022192781A1 (en) | 2021-03-12 | 2022-03-14 | Phenalkylamines and methods of making and using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240019063A true KR20240019063A (ko) | 2024-02-14 |
Family
ID=80999639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020237034789A Pending KR20240019063A (ko) | 2021-03-12 | 2022-03-14 | 펜알킬아민 및 이의 제조 및 사용 방법 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240166618A1 (https=) |
| EP (1) | EP4305019A1 (https=) |
| JP (1) | JP7849377B2 (https=) |
| KR (1) | KR20240019063A (https=) |
| CN (1) | CN117642379A (https=) |
| AU (1) | AU2022234444A1 (https=) |
| BR (1) | BR112023018237A2 (https=) |
| CA (1) | CA3213289A1 (https=) |
| IL (1) | IL305834A (https=) |
| MX (1) | MX2023010711A (https=) |
| WO (1) | WO2022192781A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4460489A4 (en) * | 2022-01-04 | 2026-04-08 | Bright Minds Biosciences Inc | PHENETHYLAMINES AND THEIR PREPARATION PROCESSES |
| WO2023205116A1 (en) * | 2022-04-19 | 2023-10-26 | Gilgamesh Pharmaceuticals, Inc. | Pyridine derivatives for treating psychiatric disorders |
| AR130467A1 (es) * | 2022-09-12 | 2024-12-11 | Gilgamesh Pharmaceuticals Inc | Fenalquilaminas y métodos para fabricar y usar las mismas |
| WO2025085701A1 (en) * | 2023-10-18 | 2025-04-24 | Gilgamesh Pharmaceuticals, Inc. | Pyridine derivatives for treating psychiatric disorders |
| CN119827467B (zh) * | 2025-01-10 | 2026-03-24 | 中国科学技术大学 | 酰亚胺类化合物用于阿片类毒品的光激活荧光检测方法 |
| CN120271454B (zh) * | 2025-04-01 | 2026-01-06 | 衢州凯沃化工有限公司 | 一种光催化合成含七氟异丙基取代的苯胺化合物的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1643310A1 (de) * | 1966-12-29 | 1971-06-03 | Dow Chemical Co | 4-Alkyl-2,5-dimethoxy-alpha-methyl-phenaethylamin und seine pharmakologisch vertraeglichen Salze |
| TW200744567A (en) * | 2005-09-23 | 2007-12-16 | Alcon Inc | Phenylethylamine analogs and their use for treating glaucoma |
-
2022
- 2022-03-14 JP JP2023555630A patent/JP7849377B2/ja active Active
- 2022-03-14 KR KR1020237034789A patent/KR20240019063A/ko active Pending
- 2022-03-14 CA CA3213289A patent/CA3213289A1/en active Pending
- 2022-03-14 WO PCT/US2022/020196 patent/WO2022192781A1/en not_active Ceased
- 2022-03-14 EP EP22714085.2A patent/EP4305019A1/en active Pending
- 2022-03-14 MX MX2023010711A patent/MX2023010711A/es unknown
- 2022-03-14 IL IL305834A patent/IL305834A/en unknown
- 2022-03-14 AU AU2022234444A patent/AU2022234444A1/en active Pending
- 2022-03-14 BR BR112023018237A patent/BR112023018237A2/pt unknown
- 2022-03-14 CN CN202280034218.1A patent/CN117642379A/zh active Pending
- 2022-03-14 US US18/281,127 patent/US20240166618A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3213289A1 (en) | 2022-09-15 |
| JP2024512425A (ja) | 2024-03-19 |
| BR112023018237A2 (pt) | 2023-11-28 |
| MX2023010711A (es) | 2023-11-10 |
| WO2022192781A1 (en) | 2022-09-15 |
| EP4305019A1 (en) | 2024-01-17 |
| JP7849377B2 (ja) | 2026-04-21 |
| CN117642379A (zh) | 2024-03-01 |
| AU2022234444A1 (en) | 2023-09-28 |
| IL305834A (en) | 2023-11-01 |
| US20240166618A1 (en) | 2024-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20240019063A (ko) | 펜알킬아민 및 이의 제조 및 사용 방법 | |
| EP3697759B1 (en) | MUSCARINIC ACETYLCHOLINE RECEPTOR M4 ANTAGONISTS | |
| CN114945566A (zh) | 作为钠通道调节剂的取代四氢呋喃 | |
| US20240368151A1 (en) | Novel ergolines and methods of treating mood disorders | |
| CN109496213B (zh) | 螺环化合物及其制备和使用方法 | |
| WO2017087858A1 (en) | Pyrazole compounds and methods of making and using same | |
| US20230116703A1 (en) | Novel ergolines and methods of treating mood disorders | |
| KR20240128059A (ko) | 화합물 | |
| CN111032034A (zh) | 螺环化合物及其制造和使用方法 | |
| JP2015529238A (ja) | 新規二環式ピリジノン | |
| US12428373B2 (en) | Dopamine D2 receptor ligands | |
| EP3697781B1 (en) | Antagonists of the muscarinic acetylcholine receptor m4 | |
| TW201718550A (zh) | 煙麯黴醇(fumagillol)雜環化合物及其製造及使用方法 | |
| TWI743088B (zh) | 作爲免疫調節劑的三並環化合物 | |
| JP2019023225A (ja) | ヘテロアリール化合物及びその使用方法 | |
| WO2022261427A1 (en) | (4-(6-((2-octahydrocyclopenta[c]pyrrol-5-yl)amino)pyridazin-3-yl)phenyl)(imino)(methyl)-lambda6- sulfanone derivatives and similar compounds as muscarinic acetylcholine receptor m4 antagonists for the treatment of neurodegenerative disorders | |
| JP7716494B2 (ja) | Kv1.3カリウムシェーカーチャネル遮断剤としてのアリール複素環化合物 | |
| TW202340207A (zh) | Klf2誘導劑及其使用方法 | |
| US12428380B2 (en) | Compounds | |
| KR20260053507A (ko) | 화합물 | |
| KR20260053282A (ko) | 정신 질환의 치료를 위한 피롤로피리딘 화합물 | |
| CN107200725B (zh) | 稠杂环类衍生物、其制备方法及其在医药上的应用 | |
| WO2026060256A1 (en) | Sting inhibitors and uses thereof | |
| CN120787225A (zh) | 新型麦角林类和治疗心境障碍的方法 | |
| HK40004417B (zh) | 螺环化合物及其制备和使用方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20231011 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20250312 Comment text: Request for Examination of Application |